Lv3
240 积分 2024-02-28 加入
Advancing COPD management through novel pharmacological agents: ensifentrine and dupilumab
2天前
已完结
Novel selective PDE4 inhibitors. 2. Synthesis and structure-activity relationships of 4-aryl-substituted cis-tetra- and cis-hexahydrophthalazinones
2天前
已完结
Idiopathic Pulmonary Fibrosis: A Comprehensive Review of Risk Factors, Genetics, Diagnosis, and Therapeutic Approaches
26天前
已完结
Intramolecular Ring-Opening Decomposition of Aryl Azetidines
27天前
已完结
Development of a Scalable Asymmetric Process for the Synthesis of Selective PDE4B Inhibitor Nerandomilast (BI 1015550)
1个月前
已完结
First drug for idiopathic pulmonary fibrosis approved in Japan
1个月前
已完结
Optimization of Beclin 1-Targeting Stapled Peptides by Staple Scanning Leads to Enhanced Antiproliferative Potency in Cancer Cells
1个月前
已完结
Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRASG12C Inhibitor
1个月前
已完结
From KRAS G12D to Pan-KRAS Inhibitors─A Journey Enabled by Synthetic Innovation and Structure-Based Drug Design
1个月前
已完结
New PROTAC Designs for Targeted Protein Degradation in 2021–2025: Novel E3 Ligases and Pre-PROTACs
2个月前
已完结
皖公网安备34019202002308
